Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jan;4(1):28-33.
doi: 10.4103/0974-2069.79619.

Trans-catheter closure of atrial septal defect: Balloon sizing or no Balloon sizing - single centre experience

Affiliations

Trans-catheter closure of atrial septal defect: Balloon sizing or no Balloon sizing - single centre experience

Saurabh Kumar Gupta et al. Ann Pediatr Cardiol. 2011 Jan.

Abstract

Background: Selecting the device size using a sizing balloon could oversize the ostium secundum atrial septal defect (OSASD) with floppy margins and at times may lead to complications. Identifying the firm margins using trans-esophageal echocardiography (TEE) and selecting appropriate-sized device optimizes ASD device closure. This retrospective study was undertaken to document the safety and feasibility of device closure without balloon sizing the defect.

Methods: Sixty-one consecutive patients who underwent trans-catheter closure of OSASD guided by balloon sizing of the defect and intra procedural fluoroscopy (group I) and 67 consecutive patients in whom TEE was used for defect sizing and as intraprocedural imaging during device deployment (group II) were compared. The procedural success rate, device characteristics, and complications were compared between the two groups.

Results: The procedure was successful in 79.7 % patients. The success rate in group II (60 of 67, 89.6%) was significantly higher than in group I (41 of 61, 67.2 %) (P = 0.002). Mean upsizing of ASD device was significantly lower in group II (P < 0.001). TEE also provided better success rate with smaller device in subjects with large ASD (>25 mm) and in those who were younger than 14 years of age. There were four cases of device embolization (two in each group); of which one died in group II despite successful surgical retrieval.

Conclusion: Balloon sizing may not be essential for successful ASD device closure. TEE-guided sizing of ASD and device deployment provides better success rate with relatively smaller sized device.

Keywords: Atrial septal defect; balloon sizing; trans-catheter closure; trans-esophageal echocardiography.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared

Figures

Figure 1
Figure 1
Procedural success in various subgroups
Figure 2
Figure 2
(a) Device upsizing from defect size measured by TEE or balloon sizing. (b) Device upsizing from defect size measured by TTE

References

    1. Berger F, Ewert P, Bjornstad PG, Dahnert I, Krings G, Brilla- Austenat I, et al. Transcatheter closure as standard treatment for most interatrial defects: Experience in 200 patients treated with the Amplatzer septal occluder. Cardiol Young. 1999;9:468–73. - PubMed
    1. Chessa M, Carminati M, Butrera G, Bini RM, Drago M, Rosti L, et al. Early and late complications associated with transcatheter occlusion of secundum atrial septal defect. J Am Coll Cardiol. 2002;39:1061–5. - PubMed
    1. Du ZD, Hijazi ZM, Kleinman CS, Silverman NH. Amplatzer investigators.Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: Results of a multicenter nonrandomized trial. J Am Coll Cardiol. 2002;39:1936–44. - PubMed
    1. Thanopoulos BD, Laskari CV, Tsaousis GS, Zarayelyan A, Vekiou A, Papadopoulos GS. Closure of atrial septal defects with the Amplatzer occlusion device: Preliminary results. J Am Coll Cardiol. 1998;31:1110–6. - PubMed
    1. Wang JK, Tsai SK, Wu MH, Lue HC. Short-and intermediate-term results of transcatheter closure of atrial septal defect with the Amplatzer septal occluder. Am Heart J. 2004;148:511–7. - PubMed